Tierra Biosciences
Tierra Biosciences is a synthetic biology company based in San Francisco, founded in 2015. The company specializes in cell-free protein synthesis technology, which accelerates the discovery and production of custom proteins. Their core innovation, the Tierra Protein Platform, is an AI-guided, automated system that allows scientists to quickly order and receive purified custom proteins, streamlining the traditionally slow cell-based production methods. The platform supports the synthesis of proteins in various quantities and can handle challenging proteins that are difficult to produce in living cells. Tierra Biosciences utilizes multiple cell-free systems from diverse life forms, enabling combinatorial protein synthesis with various DNA sequences and biochemical modifications. The company focuses on the early discovery phase of new molecules and proteins, collaborating with industrial partners to advance promising candidates toward commercialization. Their services include custom protein synthesis, protein assays, and analytics, all designed to empower researchers in synthetic biology, biotechnology, and pharmaceuticals.
Work at Tierra Biosciences in HR or recruiting? Claim this page
Headcount trend
Tierra Biosciences went from 20 employees in Oct 2024 to 10 in Sep 2026.
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Mar 2024 | Series A | $11.4M | 5 | |
| Sep 2023 | Funding | $17.6M | – | – |
| Sep 2018 | Seed | $2.6M | 3 |
Org structure
Headcount by department
Peer reviews
Worked with someone at Tierra Biosciences?
Anonymous peer reviews on OffTheRecord
Similar companies
Tierra Biosciences FAQ
How many employees does Tierra Biosciences have?
Tierra Biosciences has about 10 employees, unchanged over the 3 months to Sep 2026.
What is Tierra Biosciences's revenue per employee?
Tierra Biosciences makes about $350K in revenue per employee, based on $3.5M annual revenue and 10 employees.
How much funding has Tierra Biosciences raised?
Tierra Biosciences has raised $31.56M in total funding; its latest round was Series A in Mar 2024.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.